• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call

    3/4/25 8:00:30 AM ET
    $TOI
    Medical/Nursing Services
    Health Care
    Get the next $TOI alert in real time by email

    CERRITOS, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its fourth quarter and full year 2024 financial results after the market close on Tuesday, March 25, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).

    The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13750791. The replay will be available until Tuesday, April 1, 2025.

    Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at https://investors.theoncologyinstitute.com/.

    About The Oncology Institute

    Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

    Investors

    Solebury Strategic Communications

    [email protected]



    Primary Logo

    Get the next $TOI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TOI

    DatePrice TargetRatingAnalyst
    2/26/2024$2.50Buy
    Jefferies
    9/14/2022$7.00Buy
    Guggenheim
    8/15/2022$10.00Buy
    Jefferies
    More analyst ratings

    $TOI
    Leadership Updates

    Live Leadership Updates

    See more
    • Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute

      CERRITOS, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ:TOI) is pleased to announce the appointment of Jordan McInerney as the new Chief Development Officer (CDO), effective April 1, 2024. In this role, Mr. McInerney will spearhead growth initiatives for The Oncology Institute across diverse markets, including cultivating new partnerships with payors, driving M&A processes for acquisition targets, and establishing MSO platforms to deliver value-based oncology care nationwide. Bringing over 15 years of healthcare leadership, McInerney most recently served as the Chief Operations Officer of HOPCo Network Solutions, a subsidiary of Hea

      4/8/24 8:00:00 AM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • The Oncology Institute Names Jeremy Castle as Chief Operations Officer

      CERRITOS, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) has announced the appointment of Jeremy Castle, MBA, as Chief Operations Officer, effective September 5, 2023. In this role, Mr. Castle leads enterprise field and central operations, pharmacy, real estate, and practice integration, playing a key role in driving TOI's success as a public company. Mr. Castle joins TOI with over 15 years of oncology industry experience, and has a track record of driving growth and profitability for multi-state physician groups. He has had other senior leadership positions, including Mr. Castle having previously served as the Chief Operating Officer for United Urolog

      10/11/23 4:05:00 PM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • The Oncology Institute Announces Leadership Transition

      CERRITOS, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States, today announced that, by mutual agreement with the Board of Directors, Brad Hively will step down as Chief Executive Officer effective June 30, 2023. Dr. Daniel Virnich, the current President of TOI, will become CEO. Mr. Hively will transition to the role of Vice Chairman of the Board of Directors. Dr. Daniel Virnich has been with The Oncology Institute since 2020, initially as Chief Operating Officer before being promoted to President. He joined TOI from DaVita where he was most recently Pres

      6/12/23 6:00:00 AM ET
      $TOI
      Medical/Nursing Services
      Health Care

    $TOI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by The Oncology Institute Inc.

      SC 13D/A - Oncology Institute, Inc. (0001799191) (Subject)

      8/20/24 8:20:55 AM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13D/A filed by The Oncology Institute Inc. (Amendment)

      SC 13D/A - Oncology Institute, Inc. (0001799191) (Subject)

      1/2/24 5:06:50 PM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by The Oncology Institute Inc. (Amendment)

      SC 13G/A - Oncology Institute, Inc. (0001799191) (Subject)

      7/10/23 10:20:11 AM ET
      $TOI
      Medical/Nursing Services
      Health Care

    $TOI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Director Hively Brad bought $47,168 worth of shares (45,280 units at $1.04), increasing direct ownership by 7% to 712,033 units (SEC Form 4)

      4/A - Oncology Institute, Inc. (0001799191) (Issuer)

      4/28/25 7:20:14 PM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • Chief Medical Officer Podnos Yale was granted 157,088 shares, increasing direct ownership by 199% to 236,137 units (SEC Form 4)

      4 - Oncology Institute, Inc. (0001799191) (Issuer)

      4/2/25 6:13:01 PM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • Chief Financial Officer Carter Robert Ross was granted 197,368 shares, increasing direct ownership by 501% to 236,775 units (SEC Form 4)

      4 - Oncology Institute, Inc. (0001799191) (Issuer)

      4/2/25 5:22:47 PM ET
      $TOI
      Medical/Nursing Services
      Health Care

    $TOI
    Financials

    Live finance-specific insights

    See more
    • The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call

      CERRITOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2025 financial results after the market close on Wednesday, May 14, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and t

      4/23/25 8:00:46 AM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025

      CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2024. Recent Operational Highlights Cash flow from operations in Q4 2024 was approximately $4.2 million, due to disciplined working capital management that saw improvements across receivables, inventory, and payables.Selling, general, and administrative expenses decreased 12% in Q4 2024 as compared to the prior year period, as a result of our ongoing efforts to streamline operations, improve efficiency, and o

      3/24/25 6:01:10 AM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call

      CERRITOS, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its fourth quarter and full year 2024 financial results after the market close on Tuesday, March 25, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the

      3/4/25 8:00:30 AM ET
      $TOI
      Medical/Nursing Services
      Health Care

    $TOI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates

      CERRITOS, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI)("TOI"), one of the largest value-based oncology groups in the United States, announced today that it has been selected to present an abstract at the upcoming ASCO Annual Meeting further validating cost savings and reduced hospitalizations associated with its unique High-Value Cancer Care (HVCC) model*. The study shares new data supporting prior publications which demonstrate superior outcomes for acute-care patients when enrolled in the TOI HVCC model. "Without compromising on the clinical outcomes for our oncology patients, TOI has again demonstrated the ability to drive down both Emergency Depar

      5/8/25 8:00:10 AM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call

      CERRITOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2025 financial results after the market close on Wednesday, May 14, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and t

      4/23/25 8:00:46 AM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials

      CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Company"), a pioneer in value-based community oncology care, is proud to announce an enterprise-wide expansion of its strategic partnership with Helios Clinical Research, a nationally recognized research site network. This initiative builds upon a successful collaboration in Florida and reflects TOI's ongoing commitment to integrating clinical research into community oncology settings. "Expanding our research collaboration with Helios Clinical is a natural next step," said Daniel Virnich, MD, CEO at TOI. "They've proven to be a highly capable partner, helping us streamline study a

      4/22/25 4:05:39 PM ET
      $TOI
      Medical/Nursing Services
      Health Care

    $TOI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Director Hively Brad bought $47,168 worth of shares (45,280 units at $1.04), increasing direct ownership by 7% to 712,033 units (SEC Form 4)

      4/A - Oncology Institute, Inc. (0001799191) (Issuer)

      4/28/25 7:20:14 PM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Virnich Daniel bought $23,584 worth of shares (22,640 units at $1.04), increasing direct ownership by 3% to 724,363 units (SEC Form 4)

      4 - Oncology Institute, Inc. (0001799191) (Issuer)

      3/28/25 5:50:27 PM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • Chief Medical Officer Podnos Yale bought $9,434 worth of shares (9,056 units at $1.04), increasing direct ownership by 13% to 79,049 units (SEC Form 4)

      4 - Oncology Institute, Inc. (0001799191) (Issuer)

      3/28/25 5:48:39 PM ET
      $TOI
      Medical/Nursing Services
      Health Care

    $TOI
    SEC Filings

    See more

    $TOI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SEC Form S-3 filed by The Oncology Institute Inc.

      S-3 - Oncology Institute, Inc. (0001799191) (Filer)

      5/9/25 2:57:15 PM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • The Oncology Institute Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Oncology Institute, Inc. (0001799191) (Filer)

      5/8/25 4:55:27 PM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • The Oncology Institute Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Oncology Institute, Inc. (0001799191) (Filer)

      5/7/25 4:30:27 PM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • Jefferies resumed coverage on The Oncology Institute with a new price target

      Jefferies resumed coverage of The Oncology Institute with a rating of Buy and set a new price target of $2.50

      2/26/24 8:25:21 AM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • Guggenheim initiated coverage on The Oncology Institute with a new price target

      Guggenheim initiated coverage of The Oncology Institute with a rating of Buy and set a new price target of $7.00

      9/14/22 9:25:17 AM ET
      $TOI
      Medical/Nursing Services
      Health Care
    • Jefferies initiated coverage on The Oncology Institute with a new price target

      Jefferies initiated coverage of The Oncology Institute with a rating of Buy and set a new price target of $10.00

      8/15/22 9:26:19 AM ET
      $TOI
      Medical/Nursing Services
      Health Care